Selected research
Market Analysis & Forecast
Global Cell Line STR Identification Market Analysis and Forecast 2026-2032
Market perspective
The global Cell Line STR Identification market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Cell Line STR Identification is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cell Line STR Identification is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cell Line STR Identification is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cell Line STR Identification is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Cell Line STR Identification include Bio-Synthesis, Inc., Cell Line Genetics, Inc., Charles River Laboratories, DNA Forensics Lab India, Eurofins Genomics (Eurofins Scientific), GenomeScan, IDEXX Laboratories, Inc., Laboratory Corporation of America Holdings and Microsynth AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Cell Line STR Identification, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cell Line STR Identification, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell Line STR Identification, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell Line STR Identification revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell Line STR Identification market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell Line STR Identification revenue, projected growth trends, production technology, application and end-user industry.
Cell Line STR Identification Segment by Company
Bio-Synthesis, Inc.
Cell Line Genetics, Inc.
Charles River Laboratories
DNA Forensics Lab India
Eurofins Genomics (Eurofins Scientific)
GenomeScan
IDEXX Laboratories, Inc.
Laboratory Corporation of America Holdings
Microsynth AG
NorthGene Limited (Biofortuna Limited)
Perfectus Biomed Limited
Promega Corporation
SGS SA
Sigma-Aldrich Co. LLC. (Merck KGaA)
Thermo Fisher Scientific, Inc.
Cell Line STR Identification Segment by Type
Short Tandem Repeat (STR) Analysis
Single Nucleotide Polymorphism (SNP) Analysis
Others
Cell Line STR Identification Segment by Application
Microbial Contamination
Cell Line Identity
Genetic Stability
Virus Testing
Others
Cell Line STR Identification Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Line STR Identification market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Line STR Identification and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Line STR Identification.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Cell Line STR Identification in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Cell Line STR Identification company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Line STR Identification revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Short Tandem Repeat (STR) Analysis
- Single Nucleotide Polymorphism (SNP) Analysis
- Others
Applications
- Microbial Contamination
- Cell Line Identity
- Genetic Stability
- Virus Testing
- Others
Companies covered
- Bio-Synthesis, Inc.
- Cell Line Genetics, Inc.
- Charles River Laboratories
- DNA Forensics Lab India
- Eurofins Genomics (Eurofins Scientific)
- GenomeScan
- IDEXX Laboratories, Inc.
- Laboratory Corporation of America Holdings
- Microsynth AG
- NorthGene Limited (Biofortuna Limited)
- Perfectus Biomed Limited
- Promega Corporation
- SGS SA
- Sigma-Aldrich Co. LLC. (Merck KGaA)
- Thermo Fisher Scientific, Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cell Line STR Identification Market by Type
- 1.2.1 Global Cell Line STR Identification Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Short Tandem Repeat (STR) Analysis
- 1.2.3 Single Nucleotide Polymorphism (SNP) Analysis
- 1.2.4 Others
- 1.3 Cell Line STR Identification Market by Application
- 1.3.1 Global Cell Line STR Identification Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Microbial Contamination
- 1.3.3 Cell Line Identity
- 1.3.4 Genetic Stability
- 1.3.5 Virus Testing
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cell Line STR Identification Market Dynamics
- 2.1 Cell Line STR Identification Industry Trends
- 2.2 Cell Line STR Identification Industry Drivers
- 2.3 Cell Line STR Identification Industry Opportunities and Challenges
- 2.4 Cell Line STR Identification Industry Restraints
3 Global Growth Perspective
- 3.1 Global Cell Line STR Identification Market Perspective (2021-2032)
- 3.2 Global Cell Line STR Identification Growth Trends by Region
- 3.2.1 Global Cell Line STR Identification Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cell Line STR Identification Market Size by Region (2021-2026)
- 3.2.3 Global Cell Line STR Identification Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Cell Line STR Identification Revenue by Players
- 4.1.1 Global Cell Line STR Identification Revenue by Players (2021-2026)
- 4.1.2 Global Cell Line STR Identification Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Cell Line STR Identification Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cell Line STR Identification Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Cell Line STR Identification Key Players Headquarters & Area Served
- 4.4 Global Cell Line STR Identification Players, Product Type & Application
- 4.5 Global Cell Line STR Identification Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Cell Line STR Identification Market CR5 and HHI
- 4.6.3 2025 Cell Line STR Identification Tier 1, Tier 2, and Tier 3
5 Cell Line STR Identification Market Size by Type
- 5.1 Global Cell Line STR Identification Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Cell Line STR Identification Revenue by Type (2021-2032)
- 5.3 Global Cell Line STR Identification Revenue Market Share by Type (2021-2032)
6 Cell Line STR Identification Market Size by Application
- 6.1 Global Cell Line STR Identification Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Cell Line STR Identification Revenue by Application (2021-2032)
- 6.3 Global Cell Line STR Identification Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Bio-Synthesis, Inc.
- 7.1.1 Bio-Synthesis, Inc. Company Information
- 7.1.2 Bio-Synthesis, Inc. Business Overview
- 7.1.3 Bio-Synthesis, Inc. Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.1.4 Bio-Synthesis, Inc. Cell Line STR Identification Product Portfolio
- 7.1.5 Bio-Synthesis, Inc. Recent Developments
- 7.2 Cell Line Genetics, Inc.
- 7.2.1 Cell Line Genetics, Inc. Company Information
- 7.2.2 Cell Line Genetics, Inc. Business Overview
- 7.2.3 Cell Line Genetics, Inc. Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.2.4 Cell Line Genetics, Inc. Cell Line STR Identification Product Portfolio
- 7.2.5 Cell Line Genetics, Inc. Recent Developments
- 7.3 Charles River Laboratories
- 7.3.1 Charles River Laboratories Company Information
- 7.3.2 Charles River Laboratories Business Overview
- 7.3.3 Charles River Laboratories Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.3.4 Charles River Laboratories Cell Line STR Identification Product Portfolio
- 7.3.5 Charles River Laboratories Recent Developments
- 7.4 DNA Forensics Lab India
- 7.4.1 DNA Forensics Lab India Company Information
- 7.4.2 DNA Forensics Lab India Business Overview
- 7.4.3 DNA Forensics Lab India Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.4.4 DNA Forensics Lab India Cell Line STR Identification Product Portfolio
- 7.4.5 DNA Forensics Lab India Recent Developments
- 7.5 Eurofins Genomics (Eurofins Scientific)
- 7.5.1 Eurofins Genomics (Eurofins Scientific) Company Information
- 7.5.2 Eurofins Genomics (Eurofins Scientific) Business Overview
- 7.5.3 Eurofins Genomics (Eurofins Scientific) Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.5.4 Eurofins Genomics (Eurofins Scientific) Cell Line STR Identification Product Portfolio
- 7.5.5 Eurofins Genomics (Eurofins Scientific) Recent Developments
- 7.6 GenomeScan
- 7.6.1 GenomeScan Company Information
- 7.6.2 GenomeScan Business Overview
- 7.6.3 GenomeScan Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.6.4 GenomeScan Cell Line STR Identification Product Portfolio
- 7.6.5 GenomeScan Recent Developments
- 7.7 IDEXX Laboratories, Inc.
- 7.7.1 IDEXX Laboratories, Inc. Company Information
- 7.7.2 IDEXX Laboratories, Inc. Business Overview
- 7.7.3 IDEXX Laboratories, Inc. Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.7.4 IDEXX Laboratories, Inc. Cell Line STR Identification Product Portfolio
- 7.7.5 IDEXX Laboratories, Inc. Recent Developments
- 7.8 Laboratory Corporation of America Holdings
- 7.8.1 Laboratory Corporation of America Holdings Company Information
- 7.8.2 Laboratory Corporation of America Holdings Business Overview
- 7.8.3 Laboratory Corporation of America Holdings Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.8.4 Laboratory Corporation of America Holdings Cell Line STR Identification Product Portfolio
- 7.8.5 Laboratory Corporation of America Holdings Recent Developments
- 7.9 Microsynth AG
- 7.9.1 Microsynth AG Company Information
- 7.9.2 Microsynth AG Business Overview
- 7.9.3 Microsynth AG Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.9.4 Microsynth AG Cell Line STR Identification Product Portfolio
- 7.9.5 Microsynth AG Recent Developments
- 7.10 NorthGene Limited (Biofortuna Limited)
- 7.10.1 NorthGene Limited (Biofortuna Limited) Company Information
- 7.10.2 NorthGene Limited (Biofortuna Limited) Business Overview
- 7.10.3 NorthGene Limited (Biofortuna Limited) Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.10.4 NorthGene Limited (Biofortuna Limited) Cell Line STR Identification Product Portfolio
- 7.10.5 NorthGene Limited (Biofortuna Limited) Recent Developments
- 7.11 Perfectus Biomed Limited
- 7.11.1 Perfectus Biomed Limited Company Information
- 7.11.2 Perfectus Biomed Limited Business Overview
- 7.11.3 Perfectus Biomed Limited Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.11.4 Perfectus Biomed Limited Cell Line STR Identification Product Portfolio
- 7.11.5 Perfectus Biomed Limited Recent Developments
- 7.12 Promega Corporation
- 7.12.1 Promega Corporation Company Information
- 7.12.2 Promega Corporation Business Overview
- 7.12.3 Promega Corporation Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.12.4 Promega Corporation Cell Line STR Identification Product Portfolio
- 7.12.5 Promega Corporation Recent Developments
- 7.13 SGS SA
- 7.13.1 SGS SA Company Information
- 7.13.2 SGS SA Business Overview
- 7.13.3 SGS SA Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.13.4 SGS SA Cell Line STR Identification Product Portfolio
- 7.13.5 SGS SA Recent Developments
- 7.14 Sigma-Aldrich Co. LLC. (Merck KGaA)
- 7.14.1 Sigma-Aldrich Co. LLC. (Merck KGaA) Company Information
- 7.14.2 Sigma-Aldrich Co. LLC. (Merck KGaA) Business Overview
- 7.14.3 Sigma-Aldrich Co. LLC. (Merck KGaA) Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.14.4 Sigma-Aldrich Co. LLC. (Merck KGaA) Cell Line STR Identification Product Portfolio
- 7.14.5 Sigma-Aldrich Co. LLC. (Merck KGaA) Recent Developments
- 7.15 Thermo Fisher Scientific, Inc.
- 7.15.1 Thermo Fisher Scientific, Inc. Company Information
- 7.15.2 Thermo Fisher Scientific, Inc. Business Overview
- 7.15.3 Thermo Fisher Scientific, Inc. Cell Line STR Identification Revenue and Gross Margin (2021-2026)
- 7.15.4 Thermo Fisher Scientific, Inc. Cell Line STR Identification Product Portfolio
- 7.15.5 Thermo Fisher Scientific, Inc. Recent Developments
8 North America
- 8.1 North America Cell Line STR Identification Revenue (2021-2032)
- 8.2 North America Cell Line STR Identification Revenue by Type (2021-2032)
- 8.2.1 North America Cell Line STR Identification Revenue by Type (2021-2026)
- 8.2.2 North America Cell Line STR Identification Revenue by Type (2027-2032)
- 8.3 North America Cell Line STR Identification Revenue Share by Type (2021-2032)
- 8.4 North America Cell Line STR Identification Revenue by Application (2021-2032)
- 8.4.1 North America Cell Line STR Identification Revenue by Application (2021-2026)
- 8.4.2 North America Cell Line STR Identification Revenue by Application (2027-2032)
- 8.5 North America Cell Line STR Identification Revenue Share by Application (2021-2032)
- 8.6 North America Cell Line STR Identification Revenue by Country
- 8.6.1 North America Cell Line STR Identification Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Cell Line STR Identification Revenue by Country (2021-2026)
- 8.6.3 North America Cell Line STR Identification Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Cell Line STR Identification Revenue (2021-2032)
- 9.2 Europe Cell Line STR Identification Revenue by Type (2021-2032)
- 9.2.1 Europe Cell Line STR Identification Revenue by Type (2021-2026)
- 9.2.2 Europe Cell Line STR Identification Revenue by Type (2027-2032)
- 9.3 Europe Cell Line STR Identification Revenue Share by Type (2021-2032)
- 9.4 Europe Cell Line STR Identification Revenue by Application (2021-2032)
- 9.4.1 Europe Cell Line STR Identification Revenue by Application (2021-2026)
- 9.4.2 Europe Cell Line STR Identification Revenue by Application (2027-2032)
- 9.5 Europe Cell Line STR Identification Revenue Share by Application (2021-2032)
- 9.6 Europe Cell Line STR Identification Revenue by Country
- 9.6.1 Europe Cell Line STR Identification Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Cell Line STR Identification Revenue by Country (2021-2026)
- 9.6.3 Europe Cell Line STR Identification Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Cell Line STR Identification Revenue (2021-2032)
- 10.2 China Cell Line STR Identification Revenue by Type (2021-2032)
- 10.2.1 China Cell Line STR Identification Revenue by Type (2021-2026)
- 10.2.2 China Cell Line STR Identification Revenue by Type (2027-2032)
- 10.3 China Cell Line STR Identification Revenue Share by Type (2021-2032)
- 10.4 China Cell Line STR Identification Revenue by Application (2021-2032)
- 10.4.1 China Cell Line STR Identification Revenue by Application (2021-2026)
- 10.4.2 China Cell Line STR Identification Revenue by Application (2027-2032)
- 10.5 China Cell Line STR Identification Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cell Line STR Identification Revenue (2021-2032)
- 11.2 Asia Cell Line STR Identification Revenue by Type (2021-2032)
- 11.2.1 Asia Cell Line STR Identification Revenue by Type (2021-2026)
- 11.2.2 Asia Cell Line STR Identification Revenue by Type (2027-2032)
- 11.3 Asia Cell Line STR Identification Revenue Share by Type (2021-2032)
- 11.4 Asia Cell Line STR Identification Revenue by Application (2021-2032)
- 11.4.1 Asia Cell Line STR Identification Revenue by Application (2021-2026)
- 11.4.2 Asia Cell Line STR Identification Revenue by Application (2027-2032)
- 11.5 Asia Cell Line STR Identification Revenue Share by Application (2021-2032)
- 11.6 Asia Cell Line STR Identification Revenue by Country
- 11.6.1 Asia Cell Line STR Identification Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Cell Line STR Identification Revenue by Country (2021-2026)
- 11.6.3 Asia Cell Line STR Identification Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cell Line STR Identification Revenue (2021-2032)
- 12.2 SAMEA Cell Line STR Identification Revenue by Type (2021-2032)
- 12.2.1 SAMEA Cell Line STR Identification Revenue by Type (2021-2026)
- 12.2.2 SAMEA Cell Line STR Identification Revenue by Type (2027-2032)
- 12.3 SAMEA Cell Line STR Identification Revenue Share by Type (2021-2032)
- 12.4 SAMEA Cell Line STR Identification Revenue by Application (2021-2032)
- 12.4.1 SAMEA Cell Line STR Identification Revenue by Application (2021-2026)
- 12.4.2 SAMEA Cell Line STR Identification Revenue by Application (2027-2032)
- 12.5 SAMEA Cell Line STR Identification Revenue Share by Application (2021-2032)
- 12.6 SAMEA Cell Line STR Identification Revenue by Country
- 12.6.1 SAMEA Cell Line STR Identification Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Cell Line STR Identification Revenue by Country (2021-2026)
- 12.6.3 SAMEA Cell Line STR Identification Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst